Skip to main content

Hims Hers Health Inc (HIMS) Stock

Hims Hers Health Inc Stock Details, Movements and Public Alerts

Stock Details

Hims Hers Health Inc (HIMS), a prominent company in the healthcare sector within the drug manufacturers - specialty & generic industry, is based in USA and primarily trades on the NYSE.Currently, the stock is trading at $37.56. Over the past 52 weeks, it has ranged between $23.97 and $72.98. This places the current price at 51.5% of its 52-week high and 56.7% above its 52-week low. 0The 14-day Relative Strength Index (RSI) stands at 42.74, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $44.21 by 15.04%. Similarly, it is below its 200-day moving average of $45.89 by 18.15%. The MACD histogram is 0.50, indicating bullish momentum (MACD Line: -1.31, Signal Line: -1.81). The International Securities Identification Number (ISIN) for this stock is US4340772022. There are currently 2 active alerts set for HIMS by users.

52-Week Range

$72.98 - $23.97

-48.53% from high · +56.70% from low

Avg Daily Volume

17,835,307

20-day average

100-day avg: 27,675,211

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

70.21

Above market average

Forward P/E

57.14

Earnings expected to grow

PEG Ratio

2.07

Potentially overvalued

Price to Book

14.80

EV/EBITDA

57.69

EPS (TTM)

$0.53

Price to Sales

3.83

Beta

2.41

More volatile than market

How is HIMS valued relative to its earnings and growth?
Hims Hers Health Inc trades at a P/E ratio of 70.21, which is above the market average of approximately 20. This premium valuation suggests investors expect above-average growth or the company has competitive advantages justifying the higher multiple. Looking ahead, the forward P/E of 57.14 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of 2.07 indicates a premium valuation even accounting for growth.
What is HIMS's risk profile compared to the market?
With a beta of 2.41, Hims Hers Health Inc is significantly more volatile than the market. For every 10% market move, this stock tends to move 24% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 14.80 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

6.05%

Operating Margin

2.06%

EBITDA

$168.50M

Return on Equity

26.20%

Return on Assets

5.56%

Revenue Growth (YoY)

49.20%

Earnings Growth (YoY)

-80.30%

How profitable and efficient is HIMS's business model?
Hims Hers Health Inc achieves a profit margin of 6.05%, meaning it retains $6.05 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of 2.06% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 26.20% and ROA at 5.56%, the company generates strong returns on invested capital.
What are HIMS's recent growth trends?
Hims Hers Health Inc's revenue grew by 49.20% year-over-year, representing robust expansion that significantly outpaces typical market growth rates. This strong top-line performance suggests the company is successfully capturing market share or benefiting from favorable industry trends. Earnings decreased by 80.30% year-over-year, reflecting the bottom-line impact of business performance. These growth metrics should be evaluated against DRUG MANUFACTURERS - SPECIALTY & GENERIC industry averages for proper context.

Company Size & Market

Market Cap

$8.5B

Revenue (TTM)

$2.21B

Revenue/Share (TTM)

$9.92

Shares Outstanding

219.27M

Book Value/Share

$2.55

Asset Type

Common Stock

What is HIMS's market capitalization and position?
Hims Hers Health Inc has a market capitalization of $8.5B, classifying it as a mid-cap stock ($2B-$10B). Mid-caps often represent companies in their growth phase, offering higher growth potential than large-caps but with more stability than small-caps. They can be attractive takeover targets and may become tomorrow's large-caps. With 219.27M shares outstanding, the company's ownership is relatively concentrated. As a participant in the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry, it competes with other firms in this sector.
How does HIMS's price compare to its book value?
Hims Hers Health Inc's book value per share is $2.55, while the current stock price is $37.56, resulting in a price-to-book (P/B) ratio of 14.71. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$44.67

18.93% upside potential

Analyst Recommendations

Strong Buy

0

Buy

3

Hold

8

Sell

1

Strong Sell

2

How reliable are analyst predictions for HIMS?
14 analysts cover HIMS with 21% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The bearish sentiment could create opportunity if analysts are wrong. The consensus target of $44.67 implies 18.9% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on HIMS?
Current analyst recommendations:03 Buy, 8 Hold, 1 Sell, 2 Strong Sell. The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Dec 14, 2025, 02:05 AM

Technical Indicators

RSI (14-day)

42.74

Neutral

50-Day Moving Average

$44.21

-15.04% below MA-50

200-Day Moving Average

$45.89

-18.15% below MA-200

MACD Line

-1.31

MACD Signal

-1.81

MACD Histogram

0.50

Bullish

What does HIMS's RSI value tell investors?
The RSI (Relative Strength Index) for HIMS is currently 42.74, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
How should traders interpret HIMS's MACD and moving average crossovers?
MACD analysis shows the MACD line at -1.31 above the signal line at -1.81, with histogram at 0.50. This bullish crossover suggests upward momentum is building. The 50-day MA ($44.21) is below the 200-day MA ($45.89), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Dec 15, 2025, 12:40 AM

Active Alerts

Alert Condition
RSI Threshold Cross
Threshold
30
Created
Nov 25, 2025, 03:34 PM
Alert Condition
Forward P/E falls below
Threshold
58 x
Created
Nov 21, 2025, 03:33 PM

Stay Ahead of the Market with Hims Hers Health Inc Alerts

Set up price alerts for Hims Hers Health Inc and get notified instantly when the price hits your target. Never miss an important price movement again.